Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.39M Sell
25,928
-3,486
-12% -$1.19M 0.63% 37
2026
Q1
$10.2M Buy
29,414
+1,714
+6% +$611K 0.62% 42
2025
Q4
$9.07M Buy
27,700
+2,808
+11% +$891K 0.59% 41
2025
Q3
$7.02M Sell
24,892
-1,403
-5% -$407K 0.47% 54
2025
Q2
$7.34M Sell
26,295
-2,873
-10% -$814K 0.55% 43
2025
Q1
$9.09M Buy
29,168
+262
+0.9% +$77.4K 0.89% 26
2024
Q4
$7.53M Buy
28,906
+2,222
+8% +$659K 0.76% 33
2024
Q3
$8.6M Buy
26,684
+356
+1% +$116K 1.14% 28
2024
Q2
$8.18M Buy
26,328
+586
+2% +$172K 1.33% 21
2024
Q1
$7.29M Buy
25,742
+264
+1% +$77.2K 1.29% 23
2023
Q4
$7.34M Buy
25,478
+2,395
+10% +$653K 1.45% 21
2023
Q3
$6.2M Buy
23,083
+229
+1% +$57.1K 1.43% 23
2023
Q2
$5.07M Buy
22,854
+5,920
+35% +$1.37M 1.09% 29
2023
Q1
$4.09M Buy
16,934
+2,015
+14% +$495K 1.03% 34
2022
Q4
$3.92M Buy
+14,919
New +$4M 1.01% 32

Other funds holding AMGN

Fiduciary Alliance's AMGN Position: Q2 2026 in Review

Fiduciary Alliance reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $1.19M and leaving 25,928 shares worth $9.39M. The position accounts for 0.63% of the portfolio, ranked #37.

Fiduciary Alliance first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $10.2M in Q1 2026. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fiduciary Alliance held 25,928 shares of Amgen worth $9.39M as of Q2 2026.
  • Fiduciary Alliance sold 3,486 Amgen shares in Q2 2026, an estimated $1.19M.
  • Amgen made up 0.63% of Fiduciary Alliance's portfolio in Q2 2026, its #37 holding.
  • Fiduciary Alliance first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • Fiduciary Alliance's Amgen position peaked at $10.2M in Q1 2026.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.